A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers

The primary objective of this study is to assess the safety and tolerability of a single day dosing and separate multiple-day dosing of 18-MC HCl administered orally, each part of the study having a different set of healthy male and female volunteers.

Topic Healthy Subjects
Compound Ibogaine
Country United States of America Australia
Visit trial

Trial Details



Trial Number

Sponsors & Collaborators

MindMed
MindMed is one of the largest companies in the psychedelics space and is developing various psychedelics for mental health disorders.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.